MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ADC Therapeutics SA (ADCT) Earnings Date & Reports

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

A.I. Advisor
published Earnings

ADCT is expected to report earnings to rise 92.73% to -21 cents per share on November 10

ADC Therapeutics SA ADCT Stock Earnings Reports
Q3'26
Est.
$-0.21
Q2'26
Beat
by $0.11
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.20
Q3'25
Beat
by $0.17
The last earnings report on August 13 showed earnings per share of -10 cents, beating the estimate of -21 cents. With 1.09M shares outstanding, the current market capitalization sits at 127.23M.
View a ticker or compare two or three
ADCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Details
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
274
Web
https://www.adctherapeutics.com